INGNÂ – Inogen, Inc.
Float Short %
3.43
Margin Of Safety %
Put/Call OI Ratio
0.13
EPS Next Q Diff
-0.02
EPS Last/This Y
1.19
EPS This/Next Y
0.17
Price
5.78
Target Price
13
Analyst Recom
1
Performance Q
-15.47
Upside
-704.5%
Beta
1.78
Ticker: INGN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | INGN | 6.04 | 0.07 | 0.00 | 782 |
| 2026-01-26 | INGN | 6.01 | 0.07 | 0.00 | 780 |
| 2026-01-27 | INGN | 5.9 | 0.07 | 0.00 | 796 |
| 2026-01-28 | INGN | 5.87 | 0.07 | 0.00 | 796 |
| 2026-01-29 | INGN | 5.82 | 0.07 | 0.00 | 796 |
| 2026-01-30 | INGN | 5.91 | 0.07 | 999.99 | 799 |
| 2026-02-02 | INGN | 6.01 | 0.07 | 0.57 | 799 |
| 2026-02-03 | INGN | 5.95 | 0.08 | 0.10 | 821 |
| 2026-02-04 | INGN | 5.82 | 0.08 | 0.10 | 821 |
| 2026-02-05 | INGN | 5.66 | 0.08 | 999.99 | 832 |
| 2026-02-06 | INGN | 5.66 | 0.08 | 999.99 | 832 |
| 2026-02-09 | INGN | 5.59 | 0.08 | 999.99 | 832 |
| 2026-02-10 | INGN | 5.74 | 0.11 | 0.00 | 859 |
| 2026-02-11 | INGN | 6.13 | 0.11 | 0.00 | 858 |
| 2026-02-12 | INGN | 5.79 | 0.11 | 0.91 | 921 |
| 2026-02-13 | INGN | 5.77 | 0.11 | 0.91 | 921 |
| 2026-02-17 | INGN | 5.69 | 0.11 | 0.91 | 921 |
| 2026-02-18 | INGN | 5.82 | 0.13 | 999.99 | 966 |
| 2026-02-19 | INGN | 5.82 | 0.13 | 0.00 | 967 |
| 2026-02-20 | INGN | 5.79 | 0.13 | 0.00 | 967 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | INGN | 6.04 | 25.0 | - | -0.33 |
| 2026-01-26 | INGN | 6.02 | 25.0 | - | -0.33 |
| 2026-01-27 | INGN | 5.90 | 25.0 | - | -0.33 |
| 2026-01-28 | INGN | 5.87 | 25.0 | - | -0.33 |
| 2026-01-29 | INGN | 5.82 | 25.0 | - | -0.33 |
| 2026-01-30 | INGN | 5.92 | 25.0 | - | -0.33 |
| 2026-02-02 | INGN | 6.00 | 25.0 | - | -0.33 |
| 2026-02-03 | INGN | 5.94 | 25.0 | - | -0.33 |
| 2026-02-04 | INGN | 5.82 | 25.0 | - | -0.33 |
| 2026-02-05 | INGN | 5.67 | 25.0 | - | -0.33 |
| 2026-02-06 | INGN | 5.66 | 25.0 | - | -0.33 |
| 2026-02-09 | INGN | 5.59 | 25.0 | - | -0.33 |
| 2026-02-10 | INGN | 5.75 | 25.0 | - | -0.33 |
| 2026-02-11 | INGN | 6.13 | 25.0 | - | -0.33 |
| 2026-02-12 | INGN | 5.78 | 25.0 | - | -0.33 |
| 2026-02-13 | INGN | 5.76 | 25.0 | - | -0.33 |
| 2026-02-17 | INGN | 5.70 | 25.0 | - | -0.33 |
| 2026-02-18 | INGN | 5.84 | 25.0 | - | -0.33 |
| 2026-02-19 | INGN | 5.80 | 25.0 | - | -0.33 |
| 2026-02-20 | INGN | 5.78 | 25.0 | - | -0.33 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | INGN | 0.00 | -0.83 | 3.00 |
| 2026-01-26 | INGN | 0.00 | -0.95 | 3.00 |
| 2026-01-27 | INGN | 0.00 | -0.95 | 3.00 |
| 2026-01-28 | INGN | 0.00 | -0.95 | 3.23 |
| 2026-01-29 | INGN | 0.00 | -0.95 | 3.23 |
| 2026-01-30 | INGN | 0.00 | -0.95 | 3.23 |
| 2026-02-02 | INGN | 0.00 | -0.88 | 3.23 |
| 2026-02-03 | INGN | 0.00 | -0.88 | 3.23 |
| 2026-02-04 | INGN | 0.00 | -0.88 | 3.23 |
| 2026-02-05 | INGN | 0.00 | -0.88 | 3.23 |
| 2026-02-06 | INGN | 0.00 | -0.88 | 3.23 |
| 2026-02-09 | INGN | 0.00 | 0.33 | 3.23 |
| 2026-02-10 | INGN | 0.00 | 0.33 | 3.23 |
| 2026-02-11 | INGN | 0.00 | 0.33 | 3.43 |
| 2026-02-12 | INGN | 0.00 | 0.33 | 3.43 |
| 2026-02-13 | INGN | 0.00 | 0.33 | 3.43 |
| 2026-02-17 | INGN | 0.00 | -1.87 | 3.43 |
| 2026-02-18 | INGN | 0.00 | -1.87 | 3.43 |
| 2026-02-19 | INGN | 0.00 | -1.87 | 3.43 |
| 2026-02-20 | INGN | 0.00 | -1.87 | 3.43 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS​
-0.2
Avg. EPS Est. Current Quarter
-0.18
Avg. EPS Est. Next Quarter
-0.23
Insider Transactions
Institutional Transactions
-1.87
Beta
1.78
Average Sales Estimate Current Quarter
88
Average Sales Estimate Next Quarter
90
Fair Value
Quality Score
37
Growth Score
36
Sentiment Score
39
Actual DrawDown %
93
Max Drawdown 5-Year %
-94.9
Target Price
13
P/E
Forward P/E
PEG
P/S
0.45
P/B
0.8
P/Free Cash Flow
EPS
-1
Average EPS Est. Cur. Y​
-0.33
EPS Next Y. (Est.)
-0.16
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-7.31
Relative Volume
0.89
Return on Equity vs Sector %
-41.9
Return on Equity vs Industry %
-30.6
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.13
EBIT Estimation
Inogen, IncSector: Healthcare
Industry: Medical Devices
Employees: 766
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
stock quote shares INGNÂ – Inogen, Inc. Stock Price stock today
news today INGNÂ – Inogen, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch INGNÂ – Inogen, Inc. yahoo finance google finance
stock history INGNÂ – Inogen, Inc. invest stock market
stock prices INGN premarket after hours
ticker INGN fair value insiders trading